Literature DB >> 15365829

Angiogenesis and vascular survival ability in ovarian adenocarcinomas.

A Giatromanolaki1, E Sivridis, P Tsikouras, I Manavis, G Maroulis, M I Koukourakis.   

Abstract

This study was designed to investigate the prognostic relevance of ovarian tumour angiogenesis in terms of tumour angiogenic activity (TAA) and vascular survival ability (VSA), i.e. the ability of newly formed vessels to survive once incorporated into the main tumour mass. TAA was assessed at the edge of the invading tumour, while VSA was evaluated in inner tumour areas, always in comparison with the invading edge. A series of 46 ovarian grade-1 adenocarcinomas of the endometrioid and the serous cell type was assessed. Endothelial cells were revealed after using a standard immunohistochemical technique and the CD31 antibody. Vascular density was, in general, higher at the periphery of the tumour than in the inner tumour areas, although in both cases, a rich vascular supply was associated with a poor survival. By combining counts at the tumour edge versus inner tumour areas (edvin), four groups of tumour vascularity emerged: edvin type 1 (low TAA/low VSA), edvin type 2 (low TAA/high VSA), edvin type 3 (high TAA/low VSA) and edvin type 4 (high TAA/high VSA). Edvin type-4 tumours were related to the most unfavourable prognosis. It is concluded that VSA and TAA are complementary procedures in assessing ovarian tumour vasculature and, therefore, prognosis, and by combining the two parameters, a more precise impression of the state of vascularisation in the ovary is obtained, which may prove useful in designing anti-angiogenic therapies.

Entities:  

Mesh:

Year:  2004        PMID: 15365829     DOI: 10.1007/s00428-004-1089-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  28 in total

1.  Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells.

Authors:  W Liu; D W Davis; K Ramirez; D J McConkey; L M Ellis
Journal:  Int J Cancer       Date:  2001-04-01       Impact factor: 7.396

Review 2.  Angiogenesis, angiogenic factor expression and prognosis of gastric carcinoma.

Authors:  H Saito; S Tsujitani
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

Review 3.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid.

Authors:  J R Griffiths; D J McIntyre; F A Howe; M Stubbs
Journal:  Novartis Found Symp       Date:  2001

Review 4.  The prognostic role of angiogenesis in breast cancer.

Authors:  R D Leek
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

5.  'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; E Sivridis; K O'Byrne; K C Gatter; A L Harris
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

6.  Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.

Authors:  Rania Harfouche; Haroutioun M Hasséssian; Yang Guo; Valérie Faivre; Coimbatore B Srikant; George D Yancopoulos; Sabah N A Hussain
Journal:  Microvasc Res       Date:  2002-07       Impact factor: 3.514

7.  Tumour angiogenic activity and vascular survival ability in bladder carcinoma.

Authors:  I Papadopoulos; A Giatromanolaki; M I Koukourakis; E Sivridis
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

8.  Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas.

Authors:  G Gasparini; E Bonoldi; G Viale; P Verderio; P Boracchi; G A Panizzoni; U Radaelli; A Di Bacco; R B Guglielmi; P Bevilacqua
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

9.  Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.

Authors:  A Giatromanolaki; M I Koukourakis; D Theodossiou; K Barbatis; K O'Byrne; A L Harris; K C Gatter
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

10.  Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth.

Authors:  W D Thompson; K J Shiach; R A Fraser; L C McIntosh; J G Simpson
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.